Cargando…
Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension
BACKGROUND: The systematic use of confirmatory tests in the diagnosis of primary aldosteronism (PA) increases costs, risks and complexity to the diagnostic work-up. In light of this, some authors proposed aldosterone-to-renin (ARR) cut-offs and/or integrated flow-charts to avoid this step. Patients...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200868/ https://www.ncbi.nlm.nih.gov/pubmed/37223051 http://dx.doi.org/10.3389/fendo.2023.1145186 |
_version_ | 1785045143246602240 |
---|---|
author | Bioletto, Fabio Lopez, Chiara Bollati, Martina Arata, Stefano Procopio, Matteo Ponzetto, Federico Beccuti, Guglielmo Mengozzi, Giulio Ghigo, Ezio Maccario, Mauro Parasiliti-Caprino, Mirko |
author_facet | Bioletto, Fabio Lopez, Chiara Bollati, Martina Arata, Stefano Procopio, Matteo Ponzetto, Federico Beccuti, Guglielmo Mengozzi, Giulio Ghigo, Ezio Maccario, Mauro Parasiliti-Caprino, Mirko |
author_sort | Bioletto, Fabio |
collection | PubMed |
description | BACKGROUND: The systematic use of confirmatory tests in the diagnosis of primary aldosteronism (PA) increases costs, risks and complexity to the diagnostic work-up. In light of this, some authors proposed aldosterone-to-renin (ARR) cut-offs and/or integrated flow-charts to avoid this step. Patients with resistant hypertension (RH), however, are characterized by a dysregulated renin-angiotensin-aldosterone system, even in the absence of PA. Thus, it is unclear whether these strategies might be applied with the same diagnostic reliability in the setting of RH. METHODS: We enrolled 129 consecutive patients diagnosed with RH and no other causes of secondary hypertension. All patients underwent full biochemical assessment for PA, encompassing both basal measurements and a saline infusion test. RESULTS: 34/129 patients (26.4%) were diagnosed with PA. ARR alone provided a moderate-to-high accuracy in predicting the diagnosis of PA (AUC=0.908). Among normokalemic patients, the ARR value that maximized the diagnostic accuracy, as identified by the Youden index, was equal to 41.8 (ng/dL)/(ng/mL/h), and was characterized by a sensitivity and a specificity of 100% and 67%, respectively (AUC=0.882); an ARR > 179.6 (ng/dL)/(ng/mL/h) provided a 100% specificity for the diagnosis of PA, but was associated with a very low sensitivity of 20%. Among hypokalemic patients, the ARR value that maximized the diagnostic accuracy, as identified by the Youden index, was equal to 49.2 (ng/dL)/(ng/mL/h), and was characterized by a sensitivity and a specificity of 100% and 83%, respectively (AUC=0.941); an ARR > 104.0 (ng/dL)/(ng/mL/h) provided a 100% specificity for the diagnosis of PA, with a sensitivity of 64%. CONCLUSIONS: Among normokalemic patients, there was a wide overlap in ARR values between those with PA and those with essential RH; the possibility to skip a confirmatory test should thus be considered with caution in this setting. A better discriminating ability could be seen in the presence of hypokalemia; in this case, ARR alone may be sufficient to skip confirmatory tests in a suitable percentage of patients. |
format | Online Article Text |
id | pubmed-10200868 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102008682023-05-23 Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension Bioletto, Fabio Lopez, Chiara Bollati, Martina Arata, Stefano Procopio, Matteo Ponzetto, Federico Beccuti, Guglielmo Mengozzi, Giulio Ghigo, Ezio Maccario, Mauro Parasiliti-Caprino, Mirko Front Endocrinol (Lausanne) Endocrinology BACKGROUND: The systematic use of confirmatory tests in the diagnosis of primary aldosteronism (PA) increases costs, risks and complexity to the diagnostic work-up. In light of this, some authors proposed aldosterone-to-renin (ARR) cut-offs and/or integrated flow-charts to avoid this step. Patients with resistant hypertension (RH), however, are characterized by a dysregulated renin-angiotensin-aldosterone system, even in the absence of PA. Thus, it is unclear whether these strategies might be applied with the same diagnostic reliability in the setting of RH. METHODS: We enrolled 129 consecutive patients diagnosed with RH and no other causes of secondary hypertension. All patients underwent full biochemical assessment for PA, encompassing both basal measurements and a saline infusion test. RESULTS: 34/129 patients (26.4%) were diagnosed with PA. ARR alone provided a moderate-to-high accuracy in predicting the diagnosis of PA (AUC=0.908). Among normokalemic patients, the ARR value that maximized the diagnostic accuracy, as identified by the Youden index, was equal to 41.8 (ng/dL)/(ng/mL/h), and was characterized by a sensitivity and a specificity of 100% and 67%, respectively (AUC=0.882); an ARR > 179.6 (ng/dL)/(ng/mL/h) provided a 100% specificity for the diagnosis of PA, but was associated with a very low sensitivity of 20%. Among hypokalemic patients, the ARR value that maximized the diagnostic accuracy, as identified by the Youden index, was equal to 49.2 (ng/dL)/(ng/mL/h), and was characterized by a sensitivity and a specificity of 100% and 83%, respectively (AUC=0.941); an ARR > 104.0 (ng/dL)/(ng/mL/h) provided a 100% specificity for the diagnosis of PA, with a sensitivity of 64%. CONCLUSIONS: Among normokalemic patients, there was a wide overlap in ARR values between those with PA and those with essential RH; the possibility to skip a confirmatory test should thus be considered with caution in this setting. A better discriminating ability could be seen in the presence of hypokalemia; in this case, ARR alone may be sufficient to skip confirmatory tests in a suitable percentage of patients. Frontiers Media S.A. 2023-05-08 /pmc/articles/PMC10200868/ /pubmed/37223051 http://dx.doi.org/10.3389/fendo.2023.1145186 Text en Copyright © 2023 Bioletto, Lopez, Bollati, Arata, Procopio, Ponzetto, Beccuti, Mengozzi, Ghigo, Maccario and Parasiliti-Caprino https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Bioletto, Fabio Lopez, Chiara Bollati, Martina Arata, Stefano Procopio, Matteo Ponzetto, Federico Beccuti, Guglielmo Mengozzi, Giulio Ghigo, Ezio Maccario, Mauro Parasiliti-Caprino, Mirko Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension |
title | Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension |
title_full | Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension |
title_fullStr | Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension |
title_full_unstemmed | Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension |
title_short | Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension |
title_sort | predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200868/ https://www.ncbi.nlm.nih.gov/pubmed/37223051 http://dx.doi.org/10.3389/fendo.2023.1145186 |
work_keys_str_mv | AT biolettofabio predictiveperformanceofaldosteronetoreninratiointhediagnosisofprimaryaldosteronisminpatientswithresistanthypertension AT lopezchiara predictiveperformanceofaldosteronetoreninratiointhediagnosisofprimaryaldosteronisminpatientswithresistanthypertension AT bollatimartina predictiveperformanceofaldosteronetoreninratiointhediagnosisofprimaryaldosteronisminpatientswithresistanthypertension AT aratastefano predictiveperformanceofaldosteronetoreninratiointhediagnosisofprimaryaldosteronisminpatientswithresistanthypertension AT procopiomatteo predictiveperformanceofaldosteronetoreninratiointhediagnosisofprimaryaldosteronisminpatientswithresistanthypertension AT ponzettofederico predictiveperformanceofaldosteronetoreninratiointhediagnosisofprimaryaldosteronisminpatientswithresistanthypertension AT beccutiguglielmo predictiveperformanceofaldosteronetoreninratiointhediagnosisofprimaryaldosteronisminpatientswithresistanthypertension AT mengozzigiulio predictiveperformanceofaldosteronetoreninratiointhediagnosisofprimaryaldosteronisminpatientswithresistanthypertension AT ghigoezio predictiveperformanceofaldosteronetoreninratiointhediagnosisofprimaryaldosteronisminpatientswithresistanthypertension AT maccariomauro predictiveperformanceofaldosteronetoreninratiointhediagnosisofprimaryaldosteronisminpatientswithresistanthypertension AT parasiliticaprinomirko predictiveperformanceofaldosteronetoreninratiointhediagnosisofprimaryaldosteronisminpatientswithresistanthypertension |